title: A new case of Creutzfeldt-Jakob disease associated with human growth hormone therapy in New Zealand.
abstract: A clinically atypical, neuropathologically verified case of Creutzfeldt-Jakob disease is described in a 32-year-old New Zealand woman with idiopathic hypopituitarism who had been treated in late adolescence (1970 to 1973) with human growth hormone processed from pooled cadaveric pituitary glands.
authors.affiliation: Auckland Hospital, New Zealand.
authors.forename: M
authors.initials: M
authors.lastname: Croxson
authors.forename: P
authors.initials: P
authors.lastname: Brown
authors.forename: B
authors.initials: B
authors.lastname: Synek
authors.forename: M G
authors.initials: MG
authors.lastname: Harrington
authors.forename: R
authors.initials: R
authors.lastname: Frith
authors.forename: G
authors.initials: G
authors.lastname: Clover
authors.forename: J
authors.initials: J
authors.lastname: Wilson
authors.forename: D C
authors.initials: DC
authors.lastname: Gajdusek
mesh_terms: D000328:Adult; D000682:Amyloid / Q000302:isolation & purification; D001921:Brain / Q000473:pathology*; D001923:Brain Chemistry; D002531:Cerebellum / Q000473:pathology; D002540:Cerebral Cortex / Q000473:pathology; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis; D007562:Creutzfeldt-Jakob Syndrome / Q000209:etiology* / Q000473:pathology; D004591:Electrophoresis, Polyacrylamide Gel; D005260:Female; D013006:Growth Hormone / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007018:Hypopituitarism / Q000188:drug therapy*; D009419:Nerve Tissue Proteins / Q000032:analysis
chemical_list: D000682:Amyloid; D002556:Cerebrospinal Fluid Proteins; D009419:Nerve Tissue Proteins; D013006:Growth Hormone